Dry cow therapy is used to treat and prevent mastitis in dairy cows during the non-milking period. Moving from blanket to selective treatment improves antibiotic stewardship without compromising welfare.
Blanket antibiotic dry cow therapy, while effective at reducing mastitis, represents unnecessary antibiotic use in cows with healthy udders. The welfare principle of using effective treatments when needed while avoiding unnecessary interventions supports selective therapy. The welfare risk of selective therapy is that cows with undetected subclinical infections at drying off may develop clinical mastitis in the dry period without antibiotic protection. Robust monitoring including milk testing before drying off and teat sealant use in all cows provides equivalent mastitis protection to blanket therapy while substantially reducing antibiotic use. The welfare benefit to cows of reducing unnecessary antibiotic exposure includes lower risk of antibiotic-related side effects and maintenance of healthy gut flora.